{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:10Z","timestamp":1791429490008,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Dana-Farber Cancer Institute Ted and Eileen Pasquarello Research Fund","award":["5 P01-CA142106-07"],"award-info":[{"award-number":["5 P01-CA142106-07"]}]},{"name":"Dana-Farber Cancer Institute Ted and Eileen Pasquarello Research Fund","award":["R01-CA183559"],"award-info":[{"award-number":["R01-CA183559"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bbmt.2016.08.020","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T06:41:01Z","timestamp":1473144061000},"page":"2084-2091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Nathaniel","family":"Treister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.08.020_bib0010","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1182\/blood-2003-06-2064","article-title":"An update on how to treat chronic GVHD","volume":"102","author":"Flowers","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0015","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2012-05-393389","article-title":"How we treat oral chronic graft-versus-host disease","volume":"120","author":"Treister","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0025","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bmt.2010.5","article-title":"Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation","volume":"45","author":"Pallua","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cden.2007.10.004","article-title":"Oral graft-versus-host disease","volume":"52","author":"Schubert","year":"2008","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2014.04.009","article-title":"Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease","volume":"20","author":"Noce","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2146\/ajhp120567","article-title":"Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease","volume":"70","author":"Park","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0050","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/bmt.2009.301","article-title":"Combined topical dexamethasone\/tacrolimus therapy for management of oral chronic GVHD","volume":"45","author":"Mawardi","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-3046.2006.00666.x","article-title":"Oral graft vs. host disease in children\u2014treatment with topical tacrolimus ointment","volume":"11","author":"Albert","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.2006.07679.x","article-title":"Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease","volume":"156","author":"Fricain","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1902\/jop.2004.75.4.613","article-title":"Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report","volume":"75","author":"Sanchez","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.oraloncology.2004.02.003","article-title":"Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus","volume":"40","author":"Eckardt","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bmt.1705320","article-title":"Long-term stability of a patient-convenient 1\u2009mg\/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels","volume":"37","author":"Elefante","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ajhp\/54.2.178","article-title":"Stability of tacrolimus in an extemporaneously compounded oral liquid","volume":"54","author":"Jacobson","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0095","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.tp.0000232287.08903.1d","article-title":"Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease","volume":"82","author":"Conrotto","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bmt.1705726","article-title":"Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease","volume":"40","author":"Prot-Labarthe","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2013.137","article-title":"Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures","volume":"49","author":"Bassim","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbmt.2009.08.018","article-title":"Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)","volume":"16","author":"Elad","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/bmt.2012.285","article-title":"Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium","volume":"48","author":"Treister","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbmt.2007.06.017","article-title":"Clinical evaluation of oral chronic graft-versus-host disease","volume":"14","author":"Treister","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.020_bib0125","first-page":"135","article-title":"Recognition, incidence, and management of oral graft-versus-host disease","volume":"9","author":"Schubert","year":"1990","journal-title":"NCI Monogr"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116302956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116302956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:10Z","timestamp":1761058630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116302956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1083879116302956"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.020","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}